General Statement of Disclosure:

EQUITY INTERESTS/STOCK OPTIONS: Shockwave Medical(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Esperion Pharmaceuticals(SIGNIFICANT), Norvartis(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Sarepta(SIGNIFICANT), CVS(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), Medtronic(NONE), Johnson & Johnson(SIGNIFICANT), Elsevier(SIGNIFICANT)

View Full Disclosure